期刊文献+

粉防己碱对人肺癌A549细胞血管生成拟态的影响 被引量:3

Effects of Tetrandrine on Vasculogenic Mimicry of Human Lung Cancer A549 Cell Line
原文传递
导出
摘要 目的:研究粉防己碱对人肺癌A549细胞血管生成拟态的影响。方法:采用细胞黏附试验观察粉防己碱对A549细胞黏附作用的影响;通过细胞迁移试验检测粉防己碱对A549细胞迁移能力的影响;通过血管生成拟态试验观察粉防己碱对A549细胞体外类血管生成的作用;实时定量聚合酶链反应(RT-PCR)法检测粉防己碱对A549细胞血管生成拟态相关基因表达的影响。结果:5、10、20μmol/L粉防己碱作用A549细胞30 min后,细胞的黏附作用受到抑制,并与浓度呈正相关;与对照比较,5、10、20μmol/L粉防己碱处理A549细胞12、24 h后,A549细胞迁移数减少,A549细胞管腔形成数明显减少,管腔长度明显缩短;A549细胞以粉防己碱处理后,血管生成拟态相关基因VE-cadherin、VEGF的表达减弱。结论:粉防己碱可抑制A549细胞黏附、细胞迁移和血管生成拟态,其机制可能与抑制血管生成拟态相关基因VE-cadherin、VEGF的表达有关。 OBJECTIVE: To study the effects of tetrandrin on vasculogenic mimicry of human lung cancer A549 cell line. METHODS: The effect of tetrandrin on the cell adhesion of A549 was observed by cell adhesion assay. The effect of tetrandrin on the cell migration of A549 was studied by cell scratch adhesion test. The effect of tetrandrin on the tube-like formation of A549 cell in vitro was observed by tube formation assay. The effect of tetrandrin on the expression of A549 vasculogenic mimicry related genes was assessed by semi-quantitative RT-PCR assay. RESULTS:5,10 and 20 μmol/L tetrandrin effectively inhibited the cell adhesion of A549 cell 30 min later and was positively associated with concentration. Compared with control solution,5, 10 and 20μmol/L tetrandrin strengthened the migration of A549 cell, inecreased the number of cell tube formulation significantly and shortened the length of cell tube 12 and 24 hours later. Tetrandrin markedly inhibited the expression of vasculogenic mimicry-related genes VE-cadherin and VEGF in A549 cell. CONCLUSIONS. Tetrandrin could effectively inhibit the cell adhension and cell migration of A549, and the A549-mediated vasculogenic mimicry, which may be associated with inhibiting the expression of vasculogenic mimicry-related genes VE-cadherin and VEGF.
出处 《中国药房》 CAS CSCD 2014年第31期2898-2901,共4页 China Pharmacy
关键词 粉防己碱 人肺癌A549细胞 血管生成拟态 细胞迁移 细胞黏附 Tetrandrin Human lung cancer A549 cell line Vasculogenic mimicry Cell migration Cell adhesion
  • 相关文献

参考文献12

  • 1Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis[J]. Nature,2011,/173(7 347) : 298.
  • 2Potente M, Gerhardt H, Carmeliet P. Basic and therapeu- tic aspects of angiogenesis [J]. Cell, 2011,146 (6) : 873.
  • 3Shang B, Cao Z, Zhou Q. Progress in tumor vascular nor- malization for anticancer therapy, challenges and perspec- tives [J]. FrontMed, 2012,6( 1 ) :67.
  • 4Bao M, Cao Z, Yu D, et al. Columbamine suppresses the proliferation and neovascularization of metastatic osteosar- coma U2OS cells with low cytotoxicity [J]. Toxicol Lett, 2012,215(3):174.
  • 5Cao Z, Yu D, Fu S, et al. Lycorine hydrochloride selec- tively inhibits human ovarian cancer cell proliferation and tumor neovaseularization with very low toxicity [J]. Toxi- colLett,2013,218(2) : 174.
  • 6Bu Z, Pan Y, Shang B, et al. SZ-117, a monoclonal anti- body against matrix metalloproteinase-2 inhibits tumor cell-mediated angiogenesis[J]. Hybridoma, 2012,31 ( 1 ) : 63.
  • 7王奇巍,杨国红,林梦感,朱文君,杨义芳.植物来源抑制血管生成的活性成分研究进展[J].中草药,2010,41(5). 被引量:4
  • 8Korpanty G, Smyth E, Sullivan LA, et al. Antinangiogen- ic therepy in lung cancer: focus on vascular endothelial growth factor pathway[J]. Exp Biol Med (Maywood) , 2010,235(1):3.
  • 9Blakely C, Jahan T. Emerging antiangiogenic therapies for non-samll-cell lung cancer[J]. Expert Rev Anticancer Ther,2011,11(10) : 1 607.
  • 10Garofalo C, Surmacz. Leptin and cancer[J]. J Cell Physi-ol,2006,207(1):12.

二级参考文献37

共引文献3

同被引文献67

  • 1任丹虹,方堃,应可净.穿心莲内酯对人肺腺癌A549细胞NF-κB通路的调控作用[J].中国药理学与毒理学杂志,2010,24(2):106-110. 被引量:7
  • 2罗强,李迎春,任鸿,孙黎,郭春燕,王晖.款冬花多糖对肺腺癌A549细胞生长及凋亡的影响[J].河北北方学院学报(自然科学版),2013,29(4):63-66. 被引量:15
  • 3李巍松,施诚仁,杜勇.汉防己甲素诱导神经母细胞瘤株TGW凋亡作用的实验研究[J].临床儿科杂志,2006,24(6):512-515. 被引量:4
  • 4DANHIER F, ANSORENA E, SILVA J M, et al.PLGA-based nanoparticles : an overview of biomedical applications [ J ]. J Controlled Release, 2012,161 (2) : 505- 522.
  • 5FAROKHZAD O C, LANGER R. Impact of nanotechnology on drug delivery [ J ].ACS Nano, 2009,3 ( 1 ) : 16-20.
  • 6STEVANOVIC M, USKOKVIC D. Poly ( lactide-co-glyco- lide)-based micro and nanoparticles for the controlled drug delivery of vitamins [ J] .Curr Nanosc,2009,5(1) :1-14.
  • 7GALINDO-RODRIGUEZ S, ALLEMANN E,FESSI H, et al. Pbysicoehemieal parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods [ J ]. Pharm Res, 2004, 21 ( 8 ) : 1428-1439.
  • 8MURAKAMI H, KOBAYASHI M,TAKEUCHI H,et al.Pre-paration of poly ( DL-lactide-coglycolide ) nanoparticles by modified spontaneous emulsification solvent diffusion method[J] .Int J Pharm, 1999,187(2) : 143-152.
  • 9BESHEER A, VOGEL J, GLANZ D, et al. Characterization of PLGA nanospheres stabilized with amphiphilie polymers: hydrophobically modified hydroxyethyl starch vs pluronies [ J] .Mol Pharm,2009,6(2) :407-415.
  • 10LIOU J T, CHEN Z Y, HO L J, et al. Differential effects of triptolide and tetrandrine on activation of COX-2, NF-kappa B,and AP-1 and virus production in dengue virus-infected human lung cells [ J ]. Eur J Pharmacol, 2008,589 ( 1 - 3 ) : 288-298.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部